RxDoctor Payments Data

David Gwinn, MD

Orthopaedic Surgery · Frederick, MDNPI 1396708731

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $24,100 of the $33,050 with a category attached, or 72.9%. 19 manufacturers reported payments, led by Spine Wave, Inc. at 57.4% of the total. Reporting peaked in 2019 at $13,628 and has fallen 98.5% since, to $210 in 2025.

$33,050in general payments, 2019–2025

Across 109 payments — averaging $303.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spine Wave, Inc.$19K
  • Titan Spine, LLC$6K
  • Alphatec Spine, Inc$3K
  • Zimmer Biomet$2K
  • Nevro Corp.$705
  • Supreme Orthopedic Systems, LLC$657
  • plus $2K from 13 others

What the payments were for

  • Consulting fees$24,10073%
  • Travel & lodging$4,34313%
  • Food & beverage$3,0949%
  • Education$1,5135%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,050 in reported general payments places this provider in the 85th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$314,721
Medicare patients
376
Services billed
1,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin163$1,823
Celecoxib12$401
Meloxicam55$266
Diclofenac Sodium11$150
Cyclobenzaprine Hcl31$111
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$104
Methylprednisolone16$73

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →